# Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion

> **NCT02061813** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 40 (actual)

## Conditions studied

- Head Lice

## Interventions

- **DRUG:** Abametapir Lotion 0.74% w/w
- **DRUG:** Sodium Lauryl Sulfate
- **DRUG:** Saline 0.9%
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02061813
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-01
- **Final completion:** 2014-05
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02061813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02061813, "Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02061813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*